Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination (MVA(TB)029)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University of Cape Town
Sponsor:
Collaborators:
Medical Research Council
Wellcome Trust
DfID
Oxford University
University of Stellenbosch
Oxford-Emergent Tuberculosis Consortium
Information provided by (Responsible Party):
Mark Hatherill, University of Cape Town
ClinicalTrials.gov Identifier:
NCT01650389
First received: July 23, 2012
Last updated: January 30, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given